Target intelligence / Profile preview

Slit guidance ligand 3 (SLIT3)

Target
SLIT3
Molecular classification
Secreted protein, Ligand, Axon guidance molecule, Signaling molecule, Other (extracellular matrix glycoprotein)
01

Overview

Slit guidance ligand 3 (SLIT3) is a secreted glycoprotein that belongs to the Slit family, characterized by four leucine-rich repeat (LRR) domains, several epidermal growth factor (EGF)-like domains, and a C-terminal cystine knot[1][8]. SLIT3 primarily functions as a ligand for Robo family receptors (notably Robo1 and Robo4). It serves crucial roles in axon guidance in the nervous system, where it acts as a midline repellent, but is also essential for non-neuronal processes such as promoting angiogenesis, bone remodeling, and sympathetic innervation of brown adipose tissue[4][2][6]. SLIT3 is highly conserved and predominantly expressed in the thyroid, endothelium, brown adipose tissue, and bone. Genetic variation and altered expression of SLIT3 are associated with osteoporosis, vascular disorders, neurodevelopmental diseases, and metabolic dysfunctions[10][4][5][6]. Its biological activities make it an emerging target in angiogenesis, neurodevelopment, and metabolic research, but no approved drugs currently target SLIT3 directly.

Other names
SLIT3slit homolog 3slit protein homolog 3slit-like protein 3
02

Mechanism of action

Ligand for Roundabout (Robo) family receptors, especially Robo1 and Robo4, resulting in activation of Rho and Rac GTPases to modulate cell migration and angiogenesis[2][6].

03

Biological functions

Axon guidanceCell migrationAngiogenesisCell proliferationBone remodelingSignal transduction
04

Disease associations

CancerOsteoporosisCardiometabolic diseaseNeurodegenerative diseaseOther (developmental disorders related to muscle/diaphragm/kidney)
05

Safety considerations

Potential risks with dysregulation: aberrant angiogenesis, altered nervous system wiring, bone disorders, and unwanted effects on metabolic tissues[5][2][10].
06

Biomarkers

SLIT3 gene polymorphism (e.g., rs10036727) associated with osteoporosis[10]SLIT3 levels as a possible marker for angiogenic or neurovascular status

Beyond the preview

Go deeper on Slit guidance ligand 3 (SLIT3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Slit guidance ligand 3 (SLIT3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call